| scholarly article | Q13442814 |
| P356 | DOI | 10.3727/096368911X627408 |
| P698 | PubMed publication ID | 22405036 |
| P2093 | author name string | Feng Wang | |
| Amit Sharma | |||
| Shinji Yamamoto | |||
| Xiaohui Jia | |||
| Makiko Kumagai-Braesch | |||
| Anne K Sörenby | |||
| Annika B Tibell | |||
| Annika M Wernerson | |||
| P2860 | cites work | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
| Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats | Q28578709 | ||
| Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets | Q28591503 | ||
| Inflammation blockade improves pancreatic islet function | Q30435500 | ||
| Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. | Q33215328 | ||
| Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression | Q34770083 | ||
| Islet transplantation for brittle type 1 diabetes: the UIC protocol | Q34774804 | ||
| Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept | Q37381194 | ||
| Glucagon-like peptide-1 analog and insulin combination therapy in the management of adults with type 2 diabetes mellitus | Q37763417 | ||
| Beneficial effects of desferrioxamine on encapsulated human islets--in vitro and in vivo study | Q39677920 | ||
| Establishment of mouse pancreatic stem cell line | Q39796077 | ||
| Further Characterization of a Rat Ovarian Testosterone Receptor with Evidence for Nuclear Translocation | Q40007274 | ||
| Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level | Q42503036 | ||
| Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells | Q42798453 | ||
| Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction | Q43225003 | ||
| Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes | Q44968815 | ||
| Improved histological evaluation of vascularity around an immunoisolation device by correlating number of vascular profiles to glucose exchange | Q45222560 | ||
| The portal immunosuppressive storm: relevance to islet transplantation? | Q45234964 | ||
| Effect of donor treatment with heparinoids on graft function after intraportal transplantation of a marginal islet mass: an experimental study | Q45248085 | ||
| Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas | Q46364782 | ||
| Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model | Q46470363 | ||
| Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment | Q46678794 | ||
| GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis | Q46796844 | ||
| Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets | Q47690560 | ||
| Beneficial role of pancreatic microenvironment for angiogenesis in transplanted pancreatic islets. | Q47708847 | ||
| Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. | Q51468524 | ||
| A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. | Q51483637 | ||
| Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? | Q52536571 | ||
| Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function. | Q53591473 | ||
| Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes. | Q53627911 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1269-1283 | |
| P577 | publication date | 2012-03-08 | |
| P1433 | published in | Cell Transplantation | Q15761863 |
| P1476 | title | Exendin-4 increases the expression of hypoxia-inducible factor-1α in rat islets and preserves the endocrine cell volume of both free and macroencapsulated islet grafts | |
| P478 | volume | 21 |
| Q39189393 | Dual factor delivery of CXCL12 and Exendin-4 for improved survival and function of encapsulated beta cells under hypoxic conditions |
| Q34512289 | Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds |
| Q53256328 | High Seeding Density Induces Local Hypoxia and Triggers a Proinflammatory Response in Isolated Human Islets. |
| Q88963353 | Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal Cells Could Control Chemically Induced Diabetes in Dogs: A Preliminary Study |
| Q56875353 | The TheraCyte™ Device Protects against Islet Allograft Rejection in Immunized Hosts |
| Q27013927 | Use of glucagon-like peptide-1 agonists to improve islet graft performance |
Search more.